{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "G",
          "alt": "S",
          "position": "2019"
        },
        "variant_string_id": "LRRK2 G2019S"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutant LRRK2 exhibits lower Akt1-phosphorylation activity than wild-type LRRK2.",
          "judgment": "Yes",
          "reasoning": "The paper discusses the functional assay involving Akt1-phosphorylation activity, which is relevant to understanding the disease mechanism."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Recombinant His-Akt1 (native) was incubated with recombinant GST-LRRK2 of the wild-type, G2019S mutant, I2020T mutant, or R1441C mutant in the presence of cold c-ATP. The phosphorylated Akt1 was subjected to Western analysis using antibodies specific to phospho-Akt1 (S473).",
          "judgment": "Yes",
          "reasoning": "The general class of assay, which involves phosphorylation activity and Western analysis, is applicable and relevant to modeling the disease mechanism.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "The phosphorylated Akt1 was subjected to Western analysis using antibodies specific to phospho-Akt1 (S473). (B) Graphical representation of the Akt1 (S473) phosphorylation level. Stars represent statistical comparisons by one-way ANOVA (n = 3).",
          "judgment": "Yes",
          "reasoning": "The paper includes basic controls by using wild-type LRRK2 as a control and multiple replicates (n = 3) for the experiments.",
          "next_step_or_outcome": "Proceed to Step 3c"
        },
        {
          "step_name": "Step 3c: Variant Controls",
          "extracted_paper_info": "The experiments included wild-type LRRK2, G2019S mutant, I2020T mutant, and R1441C mutant.",
          "judgment": "No",
          "reasoning": "There is no explicit mention of using known pathogenic or benign variants as controls; only the wild-type and the specific mutants were tested.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4a: Statistical Analyses",
          "extracted_paper_info": "Stars represent statistical comparisons by one-way ANOVA (n = 3); ⁄⁄ : p < 0.005.",
          "judgment": "Yes",
          "reasoning": "The statistical analyses are sufficient, as indicated by the one-way ANOVA with p-values provided.",
          "next_step_or_outcome": "Proceed to Step 4c"
        },
        {
          "step_name": "Step 4c: Correlate OddsPath",
          "extracted_paper_info": "The G2019S mutant exhibits lower Akt1-phosphorylation activity compared to wild-type LRRK2.",
          "judgment": "Yes",
          "reasoning": "The results indicate a significant decrease in Akt1-phosphorylation activity for the G2019S mutant, which correlates with a high OddsPath value.",
          "next_step_or_outcome": "Proceed to final evidence strength"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_very_strong"
      },
      "overall_conclusion": "The G2019S mutant shows significantly lower Akt1-phosphorylation activity than wild-type LRRK2, indicating a high pathogenic likelihood."
    },
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "I",
          "alt": "T",
          "position": "2020"
        },
        "variant_string_id": "LRRK2 I2020T"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutant LRRK2 exhibits lower Akt1-phosphorylation activity than wild-type LRRK2.",
          "judgment": "Yes",
          "reasoning": "The paper discusses the functional assay involving Akt1-phosphorylation activity, which is relevant to understanding the disease mechanism."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Recombinant His-Akt1 (native) was incubated with recombinant GST-LRRK2 of the wild-type, G2019S mutant, I2020T mutant, or R1441C mutant in the presence of cold c-ATP. The phosphorylated Akt1 was subjected to Western analysis using antibodies specific to phospho-Akt1 (S473).",
          "judgment": "Yes",
          "reasoning": "The general class of assay, which involves phosphorylation activity and Western analysis, is applicable and relevant to modeling the disease mechanism.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "The phosphorylated Akt1 was subjected to Western analysis using antibodies specific to phospho-Akt1 (S473). (B) Graphical representation of the Akt1 (S473) phosphorylation level. Stars represent statistical comparisons by one-way ANOVA (n = 3).",
          "judgment": "Yes",
          "reasoning": "The paper includes basic controls by using wild-type LRRK2 as a control and multiple replicates (n = 3) for the experiments.",
          "next_step_or_outcome": "Proceed to Step 3c"
        },
        {
          "step_name": "Step 3c: Variant Controls",
          "extracted_paper_info": "The experiments included wild-type LRRK2, G2019S mutant, I2020T mutant, and R1441C mutant.",
          "judgment": "No",
          "reasoning": "There is no explicit mention of using known pathogenic or benign variants as controls; only the wild-type and the specific mutants were tested.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4a: Statistical Analyses",
          "extracted_paper_info": "Stars represent statistical comparisons by one-way ANOVA (n = 3); ⁄⁄ : p < 0.005.",
          "judgment": "Yes",
          "reasoning": "The statistical analyses are sufficient, as indicated by the one-way ANOVA with p-values provided.",
          "next_step_or_outcome": "Proceed to Step 4c"
        },
        {
          "step_name": "Step 4c: Correlate OddsPath",
          "extracted_paper_info": "The I2020T mutant exhibits lower Akt1-phosphorylation activity compared to wild-type LRRK2.",
          "judgment": "Yes",
          "reasoning": "The results indicate a significant decrease in Akt1-phosphorylation activity for the I2020T mutant, which correlates with a high OddsPath value.",
          "next_step_or_outcome": "Proceed to final evidence strength"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_very_strong"
      },
      "overall_conclusion": "The I2020T mutant shows significantly lower Akt1-phosphorylation activity than wild-type LRRK2, indicating a high pathogenic likelihood."
    },
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "R",
          "alt": "C",
          "position": "1441"
        },
        "variant_string_id": "LRRK2 R1441C"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutant LRRK2 exhibits lower Akt1-phosphorylation activity than wild-type LRRK2.",
          "judgment": "Yes",
          "reasoning": "The paper discusses the functional assay involving Akt1-phosphorylation activity, which is relevant to understanding the disease mechanism."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Recombinant His-Akt1 (native) was incubated with recombinant GST-LRRK2 of the wild-type, G2019S mutant, I2020T mutant, or R1441C mutant in the presence of cold c-ATP. The phosphorylated Akt1 was subjected to Western analysis using antibodies specific to phospho-Akt1 (S473).",
          "judgment": "Yes",
          "reasoning": "The general class of assay, which involves phosphorylation activity and Western analysis, is applicable and relevant to modeling the disease mechanism.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "The phosphorylated Akt1 was subjected to Western analysis using antibodies specific to phospho-Akt1 (S473). (B) Graphical representation of the Akt1 (S473) phosphorylation level. Stars represent statistical comparisons by one-way ANOVA (n = 3).",
          "judgment": "Yes",
          "reasoning": "The paper includes basic controls by using wild-type LRRK2 as a control and multiple replicates (n = 3) for the experiments.",
          "next_step_or_outcome": "Proceed to Step 3c"
        },
        {
          "step_name": "Step 3c: Variant Controls",
          "extracted_paper_info": "The experiments included wild-type LRRK2, G2019S mutant, I2020T mutant, and R1441C mutant.",
          "judgment": "No",
          "reasoning": "There is no explicit mention of using known pathogenic or benign variants as controls; only the wild-type and the specific mutants were tested.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4a: Statistical Analyses",
          "extracted_paper_info": "Stars represent statistical comparisons by one-way ANOVA (n = 3); ⁄⁄ : p < 0.005.",
          "judgment": "Yes",
          "reasoning": "The statistical analyses are sufficient, as indicated by the one-way ANOVA with p-values provided.",
          "next_step_or_outcome": "Proceed to Step 4c"
        },
        {
          "step_name": "Step 4c: Correlate OddsPath",
          "extracted_paper_info": "The R1441C mutant exhibits lower Akt1-phosphorylation activity compared to wild-type LRRK2.",
          "judgment": "Yes",
          "reasoning": "The results indicate a significant decrease in Akt1-phosphorylation activity for the R1441C mutant, which correlates with a high OddsPath value.",
          "next_step_or_outcome": "Proceed to final evidence strength"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_very_strong"
      },
      "overall_conclusion": "The R1441C mutant shows significantly lower Akt1-phosphorylation activity than wild-type LRRK2, indicating a high pathogenic likelihood."
    }
  ]
}